Health Canada Sona Nanotech
Nova Scotia Company Waiting On Health Canada Approval For Rapid Antigen Test For Covid 19 Ctv News
Halifax Rapid Covid Testing Company Encouraged By Federal Commitment Canada News The Guardian
Sona Nanotech Limited Delivering Innovative Treatment Tools To Global Markets Canada Ca
Sona Nanotech Receives Deprioritization From Fda Health Canada Evaluation Continues Sona Nanotech Sona Nanotech
News Updates And Press Releases Sona Nanotech Sona Nanotech
Sona Nanotech Inc Posts Facebook
The first was in relation to the advantages sona s covid antigen test maintains versus the id now test just approved by health canada.
Health canada sona nanotech. Snanf the company a developer of rapid point of care diagnostic tests withdrew its application for an interim order authorization io from health canada for the marketing of its rapid covid 19 antigen test in order to obtain more clinical data to augment its submission. October 29 2020 sona nanotech inc. A developer of rapid point of care diagnostic tests received notice from the fda that the company s request for an emergency use authorization for the marketing of its rapid.
Halifax nova scotia newsfile corp. In the words of david regan. October 29 2020 halifax canada sona nanotech inc.
At the core of the firms decision is testing results from health canada were discordant with results from the firms prior analytical and clinical studies conducted by that of. Sona nanotech sona is down 50 1 per cent and is trading at c 3 80 per share. Is a nanotechnology life sciences firm that has developed multiple proprietary methods for the manufacture of various types of gold nanoparticles and used this technology to develop a covid 19 rapid antigen test.
Sona this morning elaborated on its decision to withdraw its antigen test from an application for an interim order authorization following the receipt of further data from health canada. Meanwhile the company s application with health canada remains unaffected and ongoing. Skittish investors are abandoning shares in sona nanotech sona today after its covid 19 antigen test application was downgraded by the us fda.
Snanf the company a developer of rapid point of care diagnostic tests received notice from the fda that the company s request for an emergency use authorization eua for the marketing of its rapid covid 19 antigen test in the united states is not a priority and consequently such. It is expected that sona nanotech s gold nanotechnologies may be adapted for use in applications as a safe and effective delivery system for multiple medical treatments pending the approval of various regulatory boards including health canada and the fda. Snanf the company a developer of rapid point of care diagnostic tests received notice from the fda that the company s request for an emergency use authorization eua for the marketing of its rapid covid 19 antigen test in the united states is not a priority and consequently such.
Halifax nova scotia newsfile corp.
Sona Nanotech Nanocanada
Covid 19 Global Diagnostic Consortium To Fight Pandemic Bond Digital Health
Sona Nanotech Tsxv Sona Withdraws Health Canada Application And Sends Shares Spiralling The Market Herald
Sona Nanotech Comments On Market Activity
Sona Nanotech Health Canada Evaluation Results Did Not Match Prior Analytical And Clinical Study Data The Deep Dive
Roger Taylor Dartmouth S Sona Nanotech Continues On Despite Fda Rebuff Local Business Business Saltwire
Sona Nanotech Announces Clinical Evaluation Study Results For Its Covid 19 Antigen Test Kin Communications
Sona Nanotech Announces Validation Results For Its Covid 19 Antigen Test
Sona Nanotech Inc Linkedin
Bond Digital Health On Twitter Thrilled To Announce The Signing Of A Co Marketing Agreement With Canadian Life Science Company Sona Nanotech Whose Unique Technology Is Currently Driving The Lateralflow Market More Https T Co Iyc7mxy7ia Https
Mriglobal On Twitter Mriglobal To Provide Validation Studies Of Sona Nanotech Inc S Covid 19 Rapid Detection Point Of Care Antigen Test Studies To Be Used For Health Canada Regulatory Approval And Fda For Eua Https T Co 6rzklhue6d
ｓｏｎａ On Twitter Sonananotech Notified By Fda That It S Eua Request For The Marketing Of Its Rapid Covid 19 Antigen Test In The United States Is Not A Priority And Consequently Such Authorization
Investigation Alert The Schall Law Firm Announces It Is Investigating Claims Against Sona Nanotech Inc And Encourages Investors With Losses Of 100 000 To Contact The Firm Business Wire
